Growth factors: potential therapeutic applications in neurology.

di Drago, J, Kilpatrick, T J, Koblar, S A, Talman, P S
Pubblicazione 1994

Comparative patterns of serum immunoglobulin levels in specific-pathogen-free congenitally athymic (nude), hereditarily asplenic (Dh/+), congenitally athymic-asplenic (lasat) and s...

di Eckels, D D, Gershwin, M E, Drago, J, Faulkin, L
Pubblicazione 1979

Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice

di Ryan, R E, Ross, S A, Drago, J, Loiacono, R E
Pubblicazione 2001

Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I.

di Drago, J, Murphy, M, Carroll, S M, Harvey, R P, Bartlett, P F
Pubblicazione 1991

Unsuspected abdominal aortic aneurysms as the cause of peripheral arterial occlusive disease.

di Lord, J W, Rossi, G, Daliana, M, Drago, J R, Schwartz, A M
Pubblicazione 1973

The Role of Dopamine Receptors in Regulating the Size of Axonal Arbors

di Parish, C. L., Finkelstein, D. I., Drago, J., Borrelli, E., Horne, M. K.
Pubblicato in J Neurosci (2001)

Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.

di Warner, B, Worgul, T J, Drago, J, Demers, L, Dufau, M, Max, D, Santen, R J
Pubblicazione 1983

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferator...

di Lee, S S, Pineau, T, Drago, J, Lee, E J, Owens, J W, Kroetz, D L, Fernandez-Salguero, P M, Westphal, H, Gonzalez, F J
Pubblicazione 1995

Altered striatal function in a mutant mouse lacking D1A dopamine receptors.

di Drago, J, Gerfen, C R, Lachowicz, J E, Steiner, H, Hollon, T R, Love, P E, Ooi, G T, Grinberg, A, Lee, E J, Huang, S P
Pubblicazione 1994

Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension.

di Albrecht, F E, Drago, J, Felder, R A, Printz, M P, Eisner, G M, Robillard, J E, Sibley, D R, Westphal, H J, Jose, P A
Pubblicazione 1996

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.

di Accili, D, Fishburn, C S, Drago, J, Steiner, H, Lachowicz, J E, Park, B H, Gauda, E B, Lee, E J, Cool, M H, Sibley, D R, Gerfen, C R, Westphal, H, Fuchs, S
Pubblicazione 1996